EagleBio/MutaGEL载脂蛋白B 100 PCR检测/200µL/KE09023

价格
面议
货号:KE09023
浏览量:127
品牌:EagleBio
服务
全国联保
正品保证
正规发票
签订合同
商品描述

MutaGEL Apolipoprotein B 100 PCR Assay

MutaGEL ApoB100 PCR Assay manufactured in Germany by Immundiagnostik

Size: 24 Samples
Method: PCR (allel specific)
Sample Type: DNA (e.g.whole blood, cheek swab)
Sample Size: 200 µL
For Research Use Only

Controls Included


Storage and Stability:
Store at < -18°C. The reagents are stable in the unopened micro tubes until the expiration date indicated (see print on the package). Before use: Spin tubes briefly before opening (contents may become dispersed during shipment).
Restrictions:
The PCR is resulting for all positive controls in DNA fragments of the indicated lengths and for samples at least in the amplification product of the indicated length. If this is not the case, the sample must be tested a second time or the complete analysis must be repeated with freshly isolated DNA. If there are no positive control DNA fragments present, the amplification was incorrect and the chosen PCR conditions have to be examined.

Scientific Background

Familial Hypercholesterolemia (FH) is a frequent cause of coronary artery disease in human beings. The normal removal of cholesterine from blood is interrupted, when DNA mutations of its liver receptor r-LDL make it defective or, as was found later, if the cholesterine carrier ApoB100 has gene mutations at or around codon 3500. Cd. 3500 Arg-Glu (G-A) is a mutation of Central European abundance and on average 1 of 250 persons is heterozygous for the dominant trait. The pathogenicity of the defective protein varies with further social and unknown genetic mutations: At age 50 20% of female mutation carriers have severe coronary artery disease and 40% of males. FH is easier screened for mutations of ApoB100 than for mutations of the LDL receptor gene.


Products Related to MutaGEL ApoB100 PCR Assay

MutaGEL Aldolase B PCR Assay
MutaGEL Alpha-1 Antitrypsin PCR Assay
MutaGEL HLA-DQ PCR Assay

EagleBio的iLite®分析就绪细胞iLite®  技术基于报告基因检测格式,经过修改和适用于整个药物开发周期中的应用以及生物药物的监测。这些细胞系可以开发用于任何生物制药靶标,并且可以使用相同的细胞系轻松设置药物效力(即药物活性)的测定方法。检验就绪的细胞经过基因工程处理,可与报告基因检验技术一起使用,以检测药物效力和NAb。